112¦~«×¬y·P¬Ì­]/ªÍÃì¬Ì­]±µºØ°T®§¤½§i

 


¤@. ¬y·P¬Ì­]±µºØ¨Æ¶µ»¡©ú

(¤@)            ¹ê¬I´Á¶¡

1.      ²Ä¤@¶¥¬q(112.10.02°_)

2.      ²Ä¤G¶¥¬q(112.11.01°_)

¤G. ¶}¶E¸ê°T

¤T. ¤¤©MªÀ°Ï±µºØ¯¸¸ê°T(50·³¥H¤W¦¨¤H¡A§K¦¬¶O)¡C

¥|. ¦¨¤H¬y·P¬Ì­]¨Ö©ó¤@¯ëªù¶E¶i¦æ±µºØªA°È

(!!!¦Û10/5°_¦Ü¬Ì­]¥ÎÁj!!!)

¤­. ªÍª¢Ãì²yµß¬Ì­]±µºØ¨Æ¶µ»¡©ú

¤». °Ñ¦Ò¸ê®Æ

(¤@)            °ª­·ÀIºC©Ê¯f¯e¯f¥N½X¤@Äýªí

(¤G)            ¨u¨£¯e¯f¤ÀÃþ§Ç¸¹·JÁ`ªí

(¤T)            ¬Ì­]±µºØ¶·ª¾

 


¤@. ¬y·P¬Ì­]±µºØ¨Æ¶µ»¡©ú

(¤@)            ¹ê¬I´Á¶¡

¥»°|°t¦X¬F©²¬Fµ¦¡A¦Û112.10.02°_¶}©ñ±µºØ¬y·P¬Ì­]¡A¨Ì¬Fµ¦³W¹º¤À¨â¶¥¬q¶}©ñ¡A¸Ô¦p¤Uªí©Ò¥Ü¡C

¥¥²£°ü½Ð¦Ü°ü²£¬ìªù¶E¸gÂå®vµû¦ô«á±µºØ¡A¥t°·¨àªù¶E©P¤­¤£´£¨Ñ¤½¶O¬y·P¬Ì­]±µºØªA°È¡A½Ð¤Å±¾¸¹¡C

¦¬¶O¶µ¥Ø¡G¤W¡B¤U¤Èªù¶E150/¤¸¡B©]¶¡ªù¶E200/¤¸

1.      ²Ä¤@¶¥¬q(112.10.02°_)

¶¥¬q¶¶§Ç

¹ê¬I¹ï¶H

Àˮ֤å¥ó

¦¬¶O

²Ä¤@¶¥¬q

 

112.10.02°_¦Ü¬Ì­]¥ÎÁj

65·³¥H¤WªøªÌ

(¥Á47¦~¥H«e¥X¥Í)

1.   °·«O¥d

2.   ¨­¤ÀÃÒ

150¤¸

º¡6­Ó¤ë¥H¤W¦Ü°ê¤p¤J¾Ç«e¥®¨à

1. °·«O¥d

2. ¨àµ£°·±d¤â¥U

3. ®aªø¦P·N®Ñ

150¤¸

¥¥°ü

1. °·«O¥d

2. ¨­¤ÀÃÒ

3. ¥¥°ü°·±d¤â¥U

150¤¸

°ª­·ÀIºC©Ê¯f¤H

1. °·«O¥d

2. ¨­¤ÀÃÒ

3. ¬ÛÃöÃÒ©ú¤å¥ó(³B¤èºà¡B¶EÂ_®Ñ)

150¤¸

¨u¨£¯e¯f±wªÌ

1.  °·«O¥d

2.  ¨­¤ÀÃÒ

3.  ¬ÛÃöÃÒ©ú

150¤¸

­«¤j¶Ë¯f±wªÌ

1.  °·«O¥d

2.  ¨­¤ÀÃÒ

3.  ­«¤j¶Ë¯fÃÒ©ú

150¤¸

°ê¤p¡B°ê¤¤¡B°ª¤¤¡B°ªÂ¾¡B¤­±M¤@¦Ü¤T¦~¯Å¾Ç¥Íµ¥

1. °·«O¥d

2. ¸É±µºØ³qª¾®Ñ(¾Ç®Õ»\³¹)

3. ±Ð¨|³¡¶}¥ß¤§¾Ç¥Í¨­¤ÀÃÒ©ú¬ÛÃö¤å¥ó

200¤¸

6­Ó¤ë¤ºÀ¦¨à¤§¤÷¥À

1. °·«O¥d

2. ¨­¤ÀÃÒ

3. À¦¨à¥X¥ÍÃÒ©ú

150¤¸

³]Äy·s¥_¥«§C¦¬¡B¤¤§C¦¬¤J¤á

1. °·«O¥d

2. §C¦¬¡B¤¤§C¦¬¤J¤áÃÒ©ú

100¤¸

³]Äy·s¥_¥«¨­¤ß»ÙêªÌ

1. °·«O¥d

2. ¨­¤ß»Ùê¤â¥U

100¤¸

¨ó§U½Ã¥Í³æ¦ìªA°È¤§²Ä¤@½u¬ÛÃö¤H­û

1.  °·«O¥d

2.  ¤u§@ÃѧOÃÒ

100¤¸

·s¥_¥«ÁÒ¤º²£«áÅ@²z¤§®a«DÂ卯¤u§@¤H­û

1. °·«O¥d

2. ¤u§@ÃÒ©ú¤å¥ó

100¤¸

¥»¥««È¹B¤½¥q¥q¾÷

1.  °·«O¥d

2.  ¤u§@ÃÒ©ú¤å¥ó

100¤¸

µn°O·s¥_¥«©~®a«¬¦«¨|¤H­û

1.  °·«O¥d

2.  »â¦³·s¥_¥«¬F©²ªÀ·|§½µn°OÃÒ©ú¤å¥ó

100¤¸

¦Û¶O¬Ì­]

±ý¦Û¶O±µºØ¤§¥Á²³

1. °·«O¥d

2. ¨­¤ÀÃÒ

¨Ìªù¶E¹ê»Ú¦¬¶O

2.      ²Ä¤G¶¥¬q(112.11.01°_)

¶¥¬q¶¶§Ç

¹ê¬I¹ï¶H

Àˮ֤å¥ó

¦¬¶O

²Ä¤G¶¥¬q

112.11.01°_¦Ü¬Ì­]¥ÎÁj

50-64·³¥H¤WµL°ª­·ÀIºC©Ê¯f¦¨¤H

1. °·«O¥d¡B¨­¤ÀÃÒ

150¤¸

3.      °·¨àªù¶E±µºØ®É¬q

°·¨àªù¶E

¶g¤@

¶g¤G

¶g¤T

¶g¥|

¶g¤­

¶g¤»

¤W¤È¶E

¢½

¤U¤È¶E

¢½

¢½

¢½

¢½

¤£±µºØ¬y·P¬Ì­]

 

(¤G)            ±µºØª`·N¨Æ¶µ

1.      Âå°|±µºØ¤½¶O¬y·P¬Ì­]¡A±N¨Ì¨­¤À§O°u¦¬±¾¸¹¶O¤Î±µºØ³B¸m¶O¡C

2.      ¬I¥´·í¤Ñ½Ð°È¥²Äâ±a°·«O¥d¤Î¬ÛÃöÃÒ¥ó¡A¥¼Äâ±aªÌ¤£¥i¬I¥´¡C

3.      ªì¶E½Ð°È¥²Äâ±a°·«O¥d¤Î¨­¤ÀÃÒ¡C

4.      ¿Ô¸ß±M½u¡G

l  °·±d¿Ô¸ß±M½u¡G(02)2249-0088Âà1111

l  ÃĪ«¿Ô¸ß±M½u¡G(02)2248-9211

l  ¨ä¥L¿Ô¸ß±M½u¡G(02)2249-0088Âà1080-1082

 

¤G. ¤¤©M°ÏªÀ°Ï±µºØ¯¸¸ê°T(50·³¥H¤W¦¨¤H¡A§K¦¬¶O)

(¤@)            ªA°È®É¶¡¡G½Ð¨Ì¦U¨½¦w±Æ®É¬q«e©¹¬I¥´

¤é´Á

¦aÂI

¦a§}

ªA°È®É¶¡

11/02(¥|)

©úÁJ¥«¥Á¬¡°Ê¤¤¤ß

¥Á¨Éµó114«Ñ9¸¹

17:30-19:30

11/03(¤­)

¥þÁp¤¤©M¦w¨¹©±

¦w¨¹µó18¸¹

17:30-20:30

11/03(¤­)

ÀA²±¨½¬¡°Ê¤¤¤ß

¶ê³q¸ô335«Ñ37§Ë12¸¹

17:30-19:30

11/04(¤»)

¼wÁJ°êµØ¥«¥Á¬¡°Ê¤¤¤ß

°ê¥úµó1¸¹

08:30-11:30

11/04(¤»)

¨q®p¥«¥Á¬¡°Ê¤¤¤ß

´º¼wµó25¸¹

13:30-16:30

11/04(¤»)

¿nÁJ°ê¤p

­û¤s¸ô154¸¹

08:30-16:30

11/04(¤»)

ÀA©÷¨½¨½¿ì¤½«Ç

¶ê³q¸ô367«Ñ7¸¹

17:30-19:30

11/05(¤é)

¤¤©M°ê¤¤

°ê¥úµó1¸¹

08:30-11:30

11/05(¤é)

´_¿³°ê¤p

´_¿³¸ô301«Ñ6¸¹

08:30-11:30

11/06(¤@)

¥þÁp¤¤©M·s¥Í©±

·s¥Íµó255¡B257¸¹

17:30-20:30

11/07(¤G)

®ü¤s®c

­û¤s¸ô327«Ñ42¸¹

17:30-19:30

11/09(¥|)

¦w¥­¨½¨½¥Á§ë²¼©Ò

¤¤©M¸ô350«Ñ8§Ë1-2¸¹

17:30-19:30

11/10(¤­)

³»«n¥«¥Á¬¡°Ê¤¤¤ß

¿³«n¸ô¤G¬q159«Ñ28¸¹

17:30-20:30

11/11(¤»)

¤s¥_¥«¥Á¬¡°Ê¤¤¤ß

²ø·q¸ô49«Ñ29§Ë2¸¹

08:00-12:00

11/11(¤»)

´º·s°ê¤p

´º·sµó467«Ñ37¸¹

13:30-16:30

11/11(¤»)

«È®a¤å¤Æ·|À]

´_¿³¸ô280«Ñ6¸¹

08:30-11:30

11/11(¤»)

¤¤©MÀô²y

¤¤¤s¸ô¤T¬q122¸¹

13:30-16:30

11/11(¤»)

¹Ø¼w¨½

µØ¶¶µó138¸¹

17:30-20:30

11/12(¤é)

¥Á¼w¬¡°Ê¤¤¤ß

¥Á¼w¸ô197¸¹

08:30-11:30

11/12(¤é)

¤¤©MÀô²y

¤¤¤s¸ô¤T¬q122¸¹

13:30-16:30

11/12(¤é)

¨q¤s°ê¤p

¥ß¤Hµó2¸¹

08:30-11:30

11/12(¤é)

¨q¤h¨½¿ì¤½«Ç

´º¥­¸ô111«Ñ55¸¹

13:30-15:30

11/12(¤é)

¹Ø«n¨½¿ì¤½«Ç

«n¤s¸ô320«Ñ10§Ë6¸¹

16:30-18:30

 

¤T. ªÍª¢Ãì²yµß¬Ì­]±µºØ¨Æ¶µ»¡©ú

!!¥Ø«e¥»°|µLªÍª¢Ãì²yµß¬Ì­]±µºØ!!

¤½¶O±µºØ¹ï¶H¬°65·³¥H¤WªøªÌ(47(§t)¥H«e¥X¥Í)¡A¨Ì¤£¦P±µºØ±¡§Î¡A¤À¶¥¬q¶}¥´

(¤@)          ¤½¶O¬Ì­]¡G

 

Ãþ§O

¶¥¬q

¹ê¬I¹ï¶H

¬Ì­]ºØÃþ

Àˮ֤å¥ó

¦¬¶O

¤¤¥¡¤½¶O

²Ä¤@¶¥¬q

(2023.10.02°_)

´¿±µºØ¹LPCV13(©ÎPCV15)¥B¶¡¹j¦Ü¤Ö1¦~ªÌ

PPV23

1.      °·«O¥d

2.      ¨­¤ÀÃÒ

150¤¸

²Ä¤G¶¥¬q

(2023.11.27°_)

±q¥¼´¿±µºØ¹LPCV13(©ÎPCV15)¤ÎPPV23ªÌ

PCV13

1.      °·«O¥d

2.      ¨­¤ÀÃÒ

150¤¸

²Ä¤T¶¥¬q

(2023.12.25°_)

´¿¸g±µºØPPV23¥B¶¡¹j¦Ü¤Ö1¦~ªÌ

PCV13

1.      °·«O¥d

2.      ¨­¤ÀÃÒ

150¤¸

·s¥_¦ÛÁÊ

«Ý·s¥_¥«¬F©²¤½§i

«Ý·s¥_¥«¬F©²¤½§i

 

1.      °·«O¥d

2.      ¨­¤ÀÃÒ

«Ý¤½§i

 

(¤G)          ¦Û¶O¬Ì­]¡G

Ãþ§O

¹ê¬I¹ï¶H

Àˮ֤å¥ó

¦¬¶O

¦Û¶O

±ý¦Û¶O±µºØ¤§¥Á²³

1.      °·«O¥d

2.      ¨­¤ÀÃÒ

¨Ìªù¶E¹ê»Ú¦¬¶O

 


 

¤­.°Ñ¦Ò¸ê®Æ

(¤@)            °ª­·ÀIºC©Ê¯f¯e¯f¥N½X¤@Äýªí

ICD-10

¤jÃþ

¤ÀÃþ¦WºÙ

¤¤¤å¯f¦W

ICD-10-CM
½s½X

­^¤å¯f¦W (ICD-10-CM)

B

·P¬V¯g

¤HÃþ§K¬Ì¤£¥þ¯f¬r¯e¯f©Î·P¬V

B20,Z21

B20: Human immunodeficiency virus [HIV] disease
Z21: Asymptomatic human immunodeficiency virus [HIV] infection status

D

¦å²G©M³y¦å¾¹©x¤Î¯A¤Î§K¬Ì¾÷Â઺¯e±w

§K¬Ì¯Ê¥F¯g

D80-84

D80: Immunodeficiency with predominantly antibody defects
D81: Combined immunodeficiencies
D82: Immunodeficiency associated with other major defects
D83: Common variable immunodeficiency
D84: Other immunodeficiencies

Ãþ¦×½F¯f»P¨ä¥L

D86,D89

D86: Sarcoidosis
D89: Other disorders involving the immune mechanism, not elsewhere classified

E

¤º¤À泌¡BÀç¾i©M¥NÁ¯e¯f

¿}§¿¯f

E08-13

E08: Diabetes mellitus due to underlying condition
E09: Drug or chemical induced diabetes mellitus
E10: Type 1 diabetes mellitus
E11: Type 2 diabetes mellitus
E13: Other specified diabetes mellitus

ªÎ­D¯g

E66

E66: Obesity

Ãþ¾ý¯»ÅÜ©Ê

E85

E85: Amyloidosis

G

¯«¸g¨t²Î»P·Pı¾¹©xªº¯e¯f

¤¤¼Ï¯«¸g¨t²Îµoª¢©Ê¯e¯fªº«á¿ò¯g

G09

G09: Sequelae of inflammatory diseases of central nervous system

©¬ª÷´Ë¤ó¯f

G20

G20: Parkinson's disease

ªü¯÷®üÀq¤ó¯f»P¨ä¥L¯«¸g°h¤Æ©Ê¯e¯f

G30-32

G30: Alzheimer's disease
G31: Other degenerative diseases of nervous system, not elsewhere classified
G32: Other degenerative disorders of nervous system in diseases classified elsewhere

¦hµo©Êµw¤Æ¯g»P¨ä¥L²æÅèÀT¯e¯f

G35-37

G35: Multiple sclerosis
G36: Other acute disseminated demyelination
G37: Other demyelinating diseases of central nervous system

Åöíw¤Î­«Âеo§@

G40

G40: Epilepsy and recurrent seizures

µu¼È©Ê¸£¯Ê¦åµo§@»P¸£¦åºÞ¯e¯f©Ò­Pªº¸£¦åºÞ¯g­Ô¸s

G45-46

G45: Transient cerebral ischemic attacks and related syndromes
G46: Vascular syndromes of brain in cerebrovascular diseases 

µoª¢©Ê¤Î¬r©Ê¦hµo神¸g¯fÅÜ«á¿ò¯g

G65

G65: Sequelae of inflammatory and toxic polyneuropathies

­«¯g¦ÙµL力

G70

G70: Myasthenia gravis and other myoneural disorders

¨ä¥L¤Î¥¼¯S©w¤§¦Ù¯fÅÜ

G72

G72: Other and unspecified myopathies

I

´`Àô¨t²Î
¯e¯f

­·Àã¼ö»PºC©Ê­·Àã©Ê¤ßŦ¯f

I00-02,

I05-09

I00: Rheumatic fever without heart involvement                                
I01: Rheumatic fever with heart involvement                                I02: Rheumatic chorea
I05: Rheumatic mitral valve diseases        
I06: Rheumatic aortic valve diseases          
I07: Rheumatic tricuspid valve diseases  
I08: Multiple valve diseases                        
I09: Other rheumatic heart diseases

°ª¦åÀ£¯e¯f

I11-13

I11: Hypertensive heart disease
I12: Hypertensive chronic kidney disease
I13: Hypertensive heart and chronic kidney disease

¤ßµ±µh»P¨ä¥L¯Ê¦å©Ê¤ßŦ¯f

I20-22,

I24-25

I20: Angina pectoris
I21: ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction
I22: Subsequent ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction
I24: Other acute ischemic heart diseases
I25: Chronic ischemic heart disease

ªÍ©Ê¤ßŦ¯f

I27-28

I27: Other pulmonary heart diseases
I28: Other diseases of pulmonary vessels

佤¯e¯f

I34-37

I34: Nonrheumatic mitral valve disorders


I35: Nonrheumatic aortic valve disorders


I36: Nonrheumatic tricuspid valve disorders


I37: Nonrheumatic pulmonary valve disorders

¤ß¦Ù¯fÅÜ

I42-43

I42: Cardiomyopathy
I43: Cardiomyopathy in diseases classified elsewhere

¤ßŦ¶Ç¾É
¯e¯f

I44-45,

I47-49

I44: Atrioventricular and left bundle-branch block
I45: Other conduction disorders
I47: Paroxysmal tachycardia
I48: Atrial fibrillation and flutter
I49: Other cardiac arrhythmias

¤ß°IºÜ»P
¨ä¥L

I50-51

I50: Heart failure
I51: Complications and ill-defined descriptions of heart disease

«D¥~¶Ë©Ê¸£¥X¦å

I60-62

I60: Nontraumatic subarachnoid hemorrhage
I61: Nontraumatic intracerebral hemorrhage
I62: Other and unspecified nontraumatic intracranial hemorrhage

¸£±ð¶ë

I63

I63: Cerebral infarction

¨ä¥L¸£¦åºÞ¯e¯f©Î¨ä«á¿ò¯g

I67-69

I67: Other cerebrovascular diseases
I68: Cerebrovascular disorders in diseases classified elsewhere
I69: Sequelae of cerebrovascular disease

°Ê¯ßµ°¼Ëµw¤Æ

I70

Atherosclerosis

°Ê¯ß½F

I71,72

I71: Aortic aneurysm and dissection
I72: Other aneurysm

¨ä¥L¦åºÞ
¯e¯f

I73-74,

I77, I79

I73: Other peripheral vascular diseases


I74: Arterial embolism and thrombosis


I77: Other disorders of arteries and arterioles


I79: Disorders of arteries, arterioles and capillaries in diseases classified elsewhere

J

©I§l¨t²Î
¯e¯f

¤ä®ðºÞª¢»P¨ä¥LºC©Êªý¶ë©ÊªÍ¯e¯f

J40-45

J40: Bronchitis, not specified as acute or chroni
J41: Simple and mucopurulent chronic bronchitis

J42: Unspecified chronic bronchitis
J43: Emphysema

J44: Other chronic obstructive pulmonary disease
J45: Asthma

¤ä®ðºÞ
ÂX±i¯g

J47

J47: Bronchiectasis

ªÍ¨IµÛ¯g¤Î¥~¦]©Ò­P¤§ªÍ¯e¯f

J60-70

J60: Coalworker's pneumoconiosis

J61: Pneumoconiosis due to asbestos and other mineral fibers 
J62: Pneumoconiosis due to dust containing silica
J63: Pneumoconiosis due to other inorganic dusts  

J64: Unspecified pneumoconiosis
J65: Pneumoconiosis associated with tuberculosis

J66: Airway disease due to specific organic dust
J67: Hypersensitivity pneumonitis due to organic dust

J68: Respiratory conditions due to inhalation of chemicals, gases, fumes and vapors

J69: Pneumonitis due to solids and liquids
J70: Respiratory conditions due to other external agents

¨ä¥LªÍ³¡
¯e¯f

J82,J84,J96,

J98,J99

J82: Pulmonary eosinophilia, not elsewhere classified


J84: Other interstitial pulmonary diseases


J96: Respiratory failure, not elsewhere classified


J98: Other respiratory disorders

J99: Respiratory disorders in diseases classified elsewhere

K

®ø¤Æ¨t²Î
¯e¯f

ºC©Ê¨xª¢»P¨xµw¤Æ

K70-72,

K73-76,

B18-19

K70: Alcoholic liver disease
K71: Toxic liver disease
K72: Hepatic failure
¡Anot elsewhere classified
K73: Chronic hepatitis, unspecified

K74: Fibrosis
K75: Other inflammatory disease of liver K76: other diseases of liver
B18: Chronic viral hepatitis
B19: Unspecified viral hepatitis

M

¦Ù¦×°©Àf¨t²Î¤Îµ²½l²Õ´¯e¯f

Ãþ­·Àã©ÊÃö¸`ª¢

M05-06

M05: Rheumatoid arthritis with rheumatoid factor
M06: Other rheumatoid arthritis

¥þ¨­©Ê¦ÛÅé§K¬Ì¯g­Ô¸s

M30-31, M32-34

M30: Polyarteritis nodosa and related conditions
M31: Other necrotizing vasculopathies
M32: Systemic lupus erythematosus (SLE)
M33: Dermatopolymyositis
M34: Systemic sclerosis [scleroderma]

¨ä¥Lµ²½l²Õ´¯e¯f

M35, M94.1

M35: Other systemic involvement of connective tissue
M94.1: Relapsing polychondritis

N

¥Í´Þªc§¿¨t²Î¯e¯f

µÇª¢¯g­Ô¸s

N00-01,N03,

N05

N00: Acute nephritic syndrome
N01: Rapidly progressive nephritic syndrome
N03: Chronic nephritic syndrome
N05: Unspecified nephritic syndrome

µÇ¯f¯g­Ô¸s

N04

N04: Nephrotic syndrome

ºC©ÊµÇ°IºÜ¤ÎµÇ°IºÜ¥¼©ú¥ÜªÌ

N18-19

N18: Chronic kidney disease (CKD)
N19: Unspecified kidney failure

µÇŦµäÁY

N26-27

N26: Unspecified contracted kidney

N27: Small kidney of unknown cause

Q

¥ý¤Ñ©Ê·î§Î¡BÅܧλP¬V¦âÅé²§±`

¥ý¤Ñ©Î«á¤ÑµÊŦ¯Ê·l

Q89.01,

Z90.81

Q89.01: Asplenia (congenital)
Z90.81: Post-surgical absence of spleen

 


 

(¤G)   ¨u¨£¯e¯f¤ÀÃþ§Ç¸¹·JÁ`ªí(111.07.13)

¤ÀÃþ

§Ç¸¹

¤¤¤å¯f¦W

¡]¶È¨Ñ°Ñ¦Ò¡^

­^¤å¯f¦W(ÁY¼g)

ICD-10-CM¶EÂ_¥N½X

A.¥ý¤Ñ©Ê¥NÁ²§±`

¡·A1§¿¯À´`Àô¥NÁ²§±` Urea cycle disorders ¡]°ª¦å®ò¯g¡^

A1

01

¥ý¤Ñ©Ê§¿¯À´`Àô¥NÁ»Ùê

Congenital  Urea cycle disorders

E72.20

 

02

¥ÊÓi»Ä¦å¯g

Citrullinemia

E72.23

 

03

¤AñQâBÓi»Ä¦X¦¨–¡¯Ê¥F¯g

 

Nitroacetylglutamate synthetase deficiency, NAG synthetase deficiency

E72.29

 

04

³¾Ói»Ä®ò¥ÒñQ°òÂಾ–¡¯Ê¥F¯g

Ornithine transcarbamylase deficiency

E72.4

 

05

°ª³¾Ói»Ä¦å¯g-°ª®ò¦å¯g-°ª¥ÊÓi»Ä¦å¯g¯g­Ô¸s

Hyperornithinemia-Hyperammonemia-Homocitrullinuria Syndrome

E72.4

¡· A2 Ói°ò»Ä/¦³¾÷»Ä¥NÁ²§±` Amino acid metabolic disorders / Organic acidemias

A2

01

Ói°ò»Ä¥NÁ¯e¯f

Amino acid metabolic disorders¡]Aminoacidopathies¡^

E72.8

 

02

°ª¯ÖÓi»Ä¦å¯g

Homocystinuria

E72.11

 

03

°ª¥Ò²¸Ói»Ä¦å¯g

Hypermethioninemia

E72.19

 

04

«D଩ʰª¥ÌÓi»Ä¦å¯g

Nonketotic hyperglycinemia

E72.51

 

05

­fଧ¿¯g

Phenylketouria

E70.0

 

06

¥|²B°ò³ãËï¯Ê¥F¯g

Tetrahydrobiopterin deficiency

E70.1

 

07

¿ò¶Ç©Ê°ª¹TÓi»Ä¦å¯g

Hereditary tyrosinemia

E70.21

 

08

·¬¿}§¿¯g

Maple syrup urine disease

E71.0

 

09

¦³¾÷»Ä¦å¯g

Organic acidemias

E71.118

 

10

²§¥³»Ä¦å¯g

Isovaleric acidemia

E71.110

 

11

¥³¤G»Ä§¿¯g¡A²Ä¤@«¬¡B²Ä¤G«¬

Glutaric aciduria type ¢¹¡B¢º

type I:E72.3

type11:E71.313

 

12

¤þ»Ä¦å¯g

Propionic acidemia

E71.121

 

13

¥Ò°ò¤þ¤G»Ä¦å¯g

Methylmalonic acidemia

E71.120

 

14

3-ßm°ò-3-¥Ò°ò¥³¤G»Ä¦å¯g

3-Hydroxy-3-methyl-methylglutaric acidemia

E71.118

 

15

¨å«¬­fଧ¿¯g¦X¨Ö½©¿}–¡¦P³ÁªÞ¿}–¡¯Ê¥F¯g

PAH type PKU combine with Sucrase-isomaltase deficiency

E74.31+E70.0

 

16

°ªÂ÷Ói°ò»Ä¦å¯g

Hyperlysinemia

E72.3

 

17

²ÕÓi»Ä¦å¯g

Histidinemia

E70.41

 

18

¤T¥Ò°ò¤Ú¨§ñQ»²–¡Aßn¤Æ»Ã¯À¯Ê¥F¯g

3-Methylcrotonyl-CoA carboxylase deficiency

E71.19

 

19

¦hµo©Êßn¤Æ–¡¯Ê¥F¯g

Multiple carboxylase deficiency

D81.819

 

20

°ª²ãÓi»Ä¦å¯g

Hyperprolinemia

E72.59

 

21

ªÚ­»±ÚL-Ói°ò»ÄÃþ²æßn°ò–¡¯Ê¥F¯g

Aromatic L-amino acid decarboxylase deficiency

E70.9

 

22

¹TÓi»Äßm¤Æ–¡¯Ê¥F¯g

Tyrosine hydroxylase deficiency

E70.20

 

23

¥Ò°ò¤þ¤G»Ä¦å¯g¨Ö°ª¯ÖÓi»Ä¦å¯g¡]Cbl C«¬¡^

Cobalamin C defect ¡]Methylmalonic aciduria and Homocystinuria, cbl C type¡^

E71.120+E72.11

¡· A3¯×½èÀx¿n

A3

01

°ª³·¤ó¯g

Gaucher¡¦s disease

E75.22

 

02

GM1/GM2¯«¸g¸`–£¯×Àx¿n¯g

GM1/GM2 gangliosidosis

GM1:E75.19

GM2: E75.00

 

03

Fabry ¤ó¯g

Fabry disease

E75.21

 

04

Niemann-Pick¤ó¯g¡AÀTÅèÁC¯×Àx¿n¯g

Niemann-Pick disease

E75.240:Type A

E75.241:Type B

E75.242:Type C

E75.243:Type D

E75.248:other

E75.249:unspecified

 

05

MLD¯g­Ô¸s

Metachromatic Leukodystrophy¡]MLD¡^

E75.25

 

06